Search results for "CARDIOVASCULAR DISEASE."

showing 10 items of 2331 documents

SUBFRACTIONS AND SUBPOPULATIONS OF HDL: AN UPDATE

2014

High-density lipoproteins (HDL) are classified as atheroprotective because they are involved in transport of cholesterol to the liver, known as "reverse cholesterol transport (RCT)" exerting antioxidant and anti-inflammatory activities. There is also evidence for cytoprotective, vasodilatory, antithrombotic, and anti-infectious activities for these lipoproteins. HDLs are known by structural, metabolic and biologic heterogeneity. Thus, different methods are able to distinguish several subclasses of HDL. Different separation techniques appear to support different HDL fractions as being atheroprotective or related with lower cardiovascular (CV) risk. However, HDL particles are not always prote…

medicine.medical_specialtyPharmacologyBiologySystemic inflammationBiochemistrychemistry.chemical_compoundRisk FactorsInternal medicineDrug DiscoveryAntithromboticmedicineAnimalsHumansHdl functionalityPharmacologyCholesterolOrganic ChemistryReverse cholesterol transportBiomarker (cell)EndocrinologychemistryCardiovascular DiseasesMolecular MedicineSeparation methodlipids (amino acids peptides and proteins)Hdl subfractionscardiovascular risk electrophoresis high-density lipoprotein nuclear magnetic resonance proteome subclasses subfractions ultracentrifugation.medicine.symptomLipoproteins HDL
researchProduct

European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement

2003

IntroductionOver the past 20 years or so, the accuracy of the conventional Riva-Rocci/Korotkoff technique of blood pressure measurement has been questioned and efforts have been made to improve the technique with automated devices. In the same period, recognition of the phenomenon of white-coat hype

medicine.medical_specialtyPhysiologyBlood PressureSphygmomanometer030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineInternal MedicinemedicineHumansBlood pressure monitoring030212 general & internal medicineHypertension diagnosisIntensive care medicineSocieties MedicalMicrolifebusiness.industryBlood Pressure Monitoring AmbulatoryEuropeSelf CareMasked HypertensionBlood pressureCardiovascular DiseasesHypertensionAmbulatorySelf careCardiology and Cardiovascular MedicinebusinessJournal of Hypertension
researchProduct

Physical Activity in Polluted Air—Net Benefit or Harm to Cardiovascular Health? A Comprehensive Review

2021

Both exposure to higher levels of polluted air and physical inactivity are crucial risk factors for the development and progression of major noncommunicable diseases and, in particular, of cardiovascular disease. In this context, the World Health Organization estimated 4.2 and 3.2 million global deaths per year in response to ambient air pollution and insufficient physical activity, respectively. While regular physical activity is well known to improve general health, it may also increase the uptake and deposit of air pollutants in the lungs/airways and circulation, due to increased breathing frequency and minute ventilation, thus increasing the risk of cardiovascular disease. Thus, determi…

medicine.medical_specialtyPhysiologyCardiovascular healthair pollutionClinical BiochemistryAir pollutionPhysical activityphysical activityContext (language use)ReviewRM1-950DiseaseHealth benefitsmedicine.disease_causeBiochemistrycardiovascular diseaseEnvironmental healthmedicineoxidative stressMolecular Biologyantioxidant defensebusiness.industryPublic healthCell BiologyHarminflammationTherapeutics. PharmacologybusinessAntioxidants
researchProduct

Inter-relationship between platelet-derived microparticles and oxidative stress in patients with venous thromboembolism

2020

Background: Hypercoagulative conditions play a key role in venous thromboembolism (VTE). Inflammation is currently linked to VTE, but the potential role of circulating microparticles and oxidative stress (OxS) must be elucidated. The aim of this study was to evaluate platelet-derived microparticles and surrogate OxS biomarkers in patients diagnosed with VTE through a case&ndash

medicine.medical_specialtyPhysiologyThiobarbituric acidvenous thromboembolismClinical Biochemistry030204 cardiovascular system & hematologymedicine.disease_causeBiochemistryGastroenterologyPathophysiologyArticleSuperoxide dismutase03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePlatelet degranulationInternal medicinemedicineTBARSoxidative stressPlateletcardiovascular diseases030212 general & internal medicineMolecular BiologymicroparticlesVenous thromboembolism.biologybusiness.industrylcsh:RM1-950PlateletbiomarkersCell BiologyBiomarkerequipment and suppliesMalondialdehydelcsh:Therapeutics. PharmacologyClotting timechemistryMicroparticleplateletsbiology.proteinOxidative strebusinessOxidative stress
researchProduct

Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group 'Hypertension Arrhythmias an…

2012

Hypertension is the most common cardiovascular disorder and atrial fibrillation is the most common clinically significant arrhythmia. Both these conditions frequently coexist and their prevalence increases rapidly with aging. There are different risk factors and clinical conditions predisposing to the development of atrial fibrillation, but due its high prevalence, hypertension is still the main risk factor for the development of atrial fibrillation. Several pathophysiologic mechanisms (such as structural changes, neurohormonal activation, fibrosis, atherosclerosis, etc.) have been advocated to explain the onset of atrial fibrillation. The presence of atrial fibrillation per se increases th…

medicine.medical_specialtyPhysiologymacromolecular substancesFibrosisRisk FactorsCardiovascular DisorderInternal medicineThromboembolismAtrial FibrillationInternal MedicinemedicineHumanscardiovascular diseasesRisk factorStrokeSocieties Medicalbusiness.industryWarfarinAtrial fibrillationHypertension atrial fibrillation anticoagulants antihypertensive treatmentMED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLAREmedicine.diseaseThrombosisEuropeBlood pressureHypertensionCardiologyCardiology and Cardiovascular Medicinebusinessmedicine.drugJournal of hypertension
researchProduct

Platelet Function Changes in Acute Myocardial Infarction

1984

Whether the thrombotic component of myocardial infarction is primary or secondary in a given patient, platelet function alterations can influence many mechanisms — operating at the microenvi-ronmental level — from which it depends if the thrombotic lesion grows or sends platelet emboli to the smaller myocardial vessels.

medicine.medical_specialtyPlatelet aggregationbusiness.industrymedicine.diseaseLesionInternal medicinecardiovascular systemmedicineCardiologyPlateletcardiovascular diseasesSpontaneous platelet aggregationMyocardial infarctionmedicine.symptombusiness
researchProduct

0128: CHA2DS2-VASc score estimates in-hospital mortality beyond GRACE score after acute myocardial infarction

2016

International audience; Background and aimsCHA2DS2VASc score have recently been suggested to predict death in patients with Atrial Fibrillation (AF). In acute myocardial infarction (AMI), silent AF is more common than symptomatic AF and associated with poor prognosis. In patients with AMI, we aimed to assess the distribution of CHA2DS2VASc score in patients with silent or symptomatic AF and the association of the score with mortality.Methods849 consecutive AMI were prospectively analyzed by continuous ECG monitoring (CEM) 30 sec. Symptomatic AF was defined as any AF occurring on ECG during the hospital stay, resulting in clinical symptoms or need for urgent cardioversion. The population was…

medicine.medical_specialtyPoor prognosismedicine.medical_treatment030204 cardiovascular system & hematologyCardioversion03 medical and health sciences0302 clinical medicine[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemInternal medicineAtrial FibrillationmedicineIn patientcardiovascular diseases030212 general & internal medicineMyocardial infarctionFramingham Risk ScoreIn hospital mortalitybusiness.industryAtrial fibrillation[ SDV.MHEP.CSC ] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemmedicine.disease3. Good healthmyocardial infarctionCHA2DS2–VASc scoreCardiologyCardiology and Cardiovascular MedicinebusinessArchives of Cardiovascular Diseases Supplements
researchProduct

Thrombosis

2014

Background— Thrombosis is the common pathology underlying ischemic heart disease, ischemic stroke, and venous thromboembolism (VTE). The Global Burden of Disease Study 2010 (GBD 2010) documented that ischemic heart disease and stroke collectively caused 1 in 4 deaths worldwide. GBD 2010 did not report data for VTE as a cause of death and disability. Objective— To review the literature on the global burden of disease caused by VTE. Approach and Results— We performed a systematic review of the literature on the global disease burden because of VTE in low-, middle-, and high-income countries. Studies from Western Europe, North America, Australia, and Southern Latin America (Argentina) yielded…

medicine.medical_specialtyPopulation ageingPopulationMyocardial IschemiaDisease030204 cardiovascular system & hematologyGlobal HealthCohort Studies03 medical and health sciencesLife Expectancy0302 clinical medicineCost of IllnessCause of DeathEnvironmental healthGlobal healthPrevalenceHumansMedicinecardiovascular diseases030212 general & internal medicineIntensive care medicineeducationStrokeDisease burdenCause of deathVenous Thrombosiseducation.field_of_studybusiness.industryIncidenceIncidence (epidemiology)Racial GroupsAge FactorsThrombosisVenous ThromboembolismHematologymedicine.diseaseThrombosis3. Good healthStrokePneumoniaVenous thrombosisSocial ClassQuality-Adjusted Life YearsMedical emergencyPulmonary EmbolismCardiology and Cardiovascular MedicinebusinessArteriosclerosis, Thrombosis, and Vascular Biology
researchProduct

Coronavirus disease 2019 in chronic kidney disease

2020

Abstract The clinical spectrum of coronavirus disease 2019 (COVID-19) infection ranges from asymptomatic infection to severe pneumonia with respiratory failure and even death. More severe cases with higher mortality have been reported in older patients and in those with chronic illness such as hypertension, diabetes or cardiovascular diseases. In this regard, patients with chronic kidney disease (CKD) have a higher rate of all-type infections and cardiovascular disease than the general population. A markedly altered immune system and immunosuppressed state may predispose CKD patients to infectious complications. Likewise, they have a state of chronic systemic inflammation that may increase …

medicine.medical_specialtyPopulation030232 urology & nephrologyDiseaseurologic and male genital diseasesSystemic inflammationAsymptomaticlaw.invention03 medical and health sciences0302 clinical medicinecardiovascular diseaselawChronic kidney diseaseInternal medicineDiabetes mellitusmedicineeducationCKJ ReviewstherapyTransplantationeducation.field_of_studySARS-CoV-2business.industryImmunityCOVID-19Cardiovascular diseasemedicine.diseaseimmunityIntensive care unitVirusPneumoniaNephrologyTherapymedicine.symptombusinesschronic kidney diseaseKidney diseaseClinical Kidney Journal
researchProduct

The controversial relationship between exercise and atrial fibrillation: clinical studies and pathophysiological mechanisms

2015

Atrial fibrillation is the most common clinically significant arrhythmia observed both in the general population and in competitive athletes. The most important risk factors are all preventable by regular physical activity. However, although the benefits of moderate physical activity in controlling cardiovascular risk factors and decreasing the risk of atrial fibrillation have been extensively proved, concerns have arisen about the potential negative effects of vigorous exercise, particularly in endurance athletes. Furthermore, in a subset of patients with atrial fibrillation younger than 60 years, routine evaluation does not reveal any cardiovascular disease or any other known causal facto…

medicine.medical_specialtyPopulationDiseaseatrial functionRisk FactorsFibrosisInternal medicinemedicineHumansatrial fibrillationcardiovascular diseasesVagal toneExercise physiologyeducationarrhythmias athlete’s heart atrial fibrillation atrial remodeling sports activityeducation.field_of_studybiologyexerciseAthletesbusiness.industryatrial fibrillation exercise atrial functionAtrial fibrillationAtrial RemodelingGeneral Medicinemedicine.diseasebiology.organism_classificationSettore MED/11 - Malattie Dell'Apparato CardiovascolareExercise TherapyReview articlecardiovascular systemCardiologyCardiology and Cardiovascular MedicinebusinessSports
researchProduct